Table 2.
Accesiona | Gene namea | Protein namea | PE > Cb,d | PE < Cc,d |
---|---|---|---|---|
P00740 | F9 | Coagulation factor IX | [68] | [69, 70] |
P00751 | CFB | Complement factor B | [71] | [48, 70, 72] |
P01009 | SERPINA1 | Alpha-1-antitrypsin | [48, 73–75] | [71] |
P01023 | A2M | Alpha-2-macroglobulin | [68, 71, 74, 76, 77] | |
P02649 | APOE | Apolipoprotein E | [74, 75, 78] | [76] |
P02679 | FGG | Fibrinogen gamma chain | [68, 74, 78, 79] | |
P02741 | CRP | C-reactive protein | [68, 69, 75, 76] | [80] |
P02746 | C1QB | Complement C1q subcomponent subunit B | [76] | [68, 69, 72] |
P02751 | FN1 | Fibronectin | [69–71, 74, 75, 79, 81] | [77] |
P02760 | AMBP | Protein AMBP | [73–76] | [75] |
P02766 | TTR | Transthyretin | [14, 74, 81, 82] | |
P02787 | TF | Serotransferrin | [48, 69, 78, 79] | |
P04114 | APOB | Apolipoprotein B-100 | [77] | [69, 74, 81] |
P04196 | HRG | Histidine-rich glycoprotein | [68, 69, 75, 82] | [72] |
P05155 | SERPING1 | Plasma protease C1 inhibitor | [71] | [69, 70, 77] |
P08514 | ITGA2B | Integrin alpha-IIb | [70, 83] | |
P08697 | SERPINF2 | Alpha-2-antiplasmin | [84] | [69, 70, 76] |
P09237 | MMP7 | Matrilysin | [70, 83] | |
P0C0L5 | C4B | Complement C4-B | [68, 77, 81, 83] | |
P10909 | CLU | Clusterin | [68, 73–75, 77–79, 81, 85, 86] | [76] |
P11464 | PSG1 | Pregnancy-specific B-1 glycoprotein 1 | [77] | [69, 75, 76, 84] |
P17813 | ENG | Endoglin | [69, 77, 80, 87, 88] | |
P20742 | PZP | Pregnancy zone protein | [68, 69] | [69, 74, 75] |
P22352 | GPX3 | Glutathione peroxidase 3 | [89] | [74–76] |
P36955 | SERPINF1 | Pigment epithelium-derived factor | [71, 72, 74, 81] | [76] |
P49763 | PGF | Placenta growth factor | [70, 83, 87] | |
Q14624 | ITIH4 | Inter-alpha-trypsin inhibitor heavy chain H4 | [68, 75, 76] | [72] |
Q15485 | FCN2 | Ficolin-2 | [70, 80, 90] | |
Q16610 | ECM1 | Extracellular matrix protein 1 | [87] | [69, 76, 77] |
Reference 69 reports two independent data for F9, C1QB, FN1, TF, APOB, HRG, SERPING1, SERPINF2, PSG1, ENG, PZP and ECM1 and four independent data for CRP; reference 70 reports two independent data for FCN2, CFB, MMP7 and PGF and three independent data for ITGA2B; reference 83 reports two independent data for MMP7.
aAccording to UniprotKB
bPE > C: expression levels have been described to be higher in pre-eclampsia versus control samples
cPE < C: expression levels have been described to be lower in pre-eclampsia versus control samples
dNumbers correspond to bibliographic references